SEC Form D · filed April 26, 2023
ASLAN Pharmaceuticals Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Carl Firth, Ph.D · Singapore, U0Exec · DirectorNeil Graham, Mbbs, M.D., Mph · Singapore, U0DirectorAlexandre M. Kaoukhov · Singapore, U0ExecRobert E. Hoffman · Singapore, U0DirectorKiran Asarpota · Singapore, U0ExecStephen M. Doyle · Singapore, U0ExecBen M. Goodger · Singapore, U0ExecKathleen M. Metters · Singapore, U0DirectorAndrew Howden · Singapore, U0DirectorRoozbeh Baharian · Chicago, ILExecGregory Cohen · Jacksonville, FLDirectorAlexander Sifakis · Jacksonville, FLDirectorAndrea D. Sandoval · Sulphur Springs, TXDirectorEvan Kominsky · Chicago, ILExec · DirectorDeborah M. Thomas · LUXEMBOURG CITY, LuxembourgExecGlenn R. Richter · LUXEMBOURG CITY, LuxembourgExecDamien R. Mignot · LUXEMBOURG CITY, LuxembourgDirectorDan Davidson · Southlake, TXExecRichard C. Cilento · Houston, TXExecVictoria Niklas · Houston, TXDirectorTheodore W. Coons, Jr · New York, NYDirectorJoe Benavides · New York, NYExecMichael B. Mccord · Austin, TXExec · DirectorKarl Gorin · St. Helier, Y9ExecRobert Quirke · London, United KingdomExecTara Duncan · St. Helier, Y9DirectorPaul Teske · Old Greenwich, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗